SecSonar.com

111, Inc. (YI)

111, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

111, Inc. (YI) is a Medical - Pharmaceuticals company based in CN with a market capitalization of $47.9M. Revenue declined 15.2% year-over-year and the company generated $16.9M in free cash flow. This page tracks YI's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

CN · 1.24K employees · IPO Sep 12, 2018

Valuation

Valuation & price

$5.70 · as of May 25, 2026 · -32.0% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$8.30$5.53$2.76Jul 25Dec 25Jul 26Jul 7, 25$7.49Jul 9, 25$7.53Jul 11, 25$7.50Jul 15, 25$7.40Jul 17, 25$7.54Jul 21, 25$7.59Jul 23, 25$7.35Jul 25, 25$7.32Jul 29, 25$6.99Jul 31, 25$6.87Aug 4, 25$6.91Aug 6, 25$6.76Aug 11, 25$6.86Aug 13, 25$6.30Aug 15, 25$6.75Aug 19, 25$7.00Aug 21, 25$7.13Aug 25, 25$7.08Aug 27, 25$7.00Aug 29, 25$6.43Sep 3, 25$6.00Sep 5, 25$5.71Sep 9, 25$5.92Sep 11, 25$5.79Sep 16, 25$6.03Sep 18, 25$5.42Sep 22, 25$4.91Sep 24, 25$4.88Sep 26, 25$4.71Sep 30, 25$4.55Oct 2, 25$4.61Oct 6, 25$4.57Oct 8, 25$4.79Oct 10, 25$4.38Oct 14, 25$4.35Oct 16, 25$4.40Oct 21, 25$4.54Oct 23, 25$4.45Oct 27, 25$4.54Oct 29, 25$4.39Oct 31, 25$4.37Nov 4, 25$4.44Nov 6, 25$4.29Nov 10, 25$4.11Nov 12, 25$4.08Nov 14, 25$4.08Nov 18, 25$3.90Nov 20, 25$3.69Nov 25, 25$3.50Nov 28, 25$3.71Dec 2, 25$3.75Dec 4, 25$3.77Dec 8, 25$3.90Dec 10, 25$3.86Dec 12, 25$3.61Dec 16, 25$3.42Dec 18, 25$3.67Dec 22, 25$3.17Dec 24, 25$3.09Dec 29, 25$2.86Jan 2, 26$2.76Jan 6, 26$2.86Jan 8, 26$2.85Jan 12, 26$3.65Jan 14, 26$5.76Jan 16, 26$5.65Jan 21, 26$5.33Jan 23, 26$5.13Jan 27, 26$5.25Jan 29, 26$5.17Feb 2, 26$7.40Feb 4, 26$7.63Feb 9, 26$7.20Feb 11, 26$7.86Feb 13, 26$8.10Feb 18, 26$8.24Feb 20, 26$8.18Feb 24, 26$8.30Feb 26, 26$8.08Mar 2, 26$7.90Mar 4, 26$7.65Mar 6, 26$6.96Mar 10, 26$6.84Mar 12, 26$6.48Mar 17, 26$6.84Mar 19, 26$6.59Mar 23, 26$6.70Mar 25, 26$6.29Mar 27, 26$6.24Mar 31, 26$6.52Apr 2, 26$6.44Apr 7, 26$6.22Apr 9, 26$6.41Apr 13, 26$6.79Apr 15, 26$6.99Apr 17, 26$6.73Apr 22, 26$6.75Apr 24, 26$6.80Apr 28, 26$6.55Apr 30, 26$6.20May 4, 26$5.92May 6, 26$5.71May 8, 26$6.05May 12, 26$6.07May 14, 26$6.00May 18, 26$5.85May 20, 26$5.73May 22, 26$5.70May 28, 26$5.47Jun 1, 26$5.44Jun 3, 26$5.26Jun 5, 26$4.78Jun 9, 26$4.40Jun 11, 26$4.28Jun 15, 26$4.57Jun 17, 26$4.41Jun 22, 26$3.70Jun 24, 26$4.01Jun 26, 26$4.08Jul 2, 26$4.13
$2.5652-week range$8.38
Loading valuation history…

Fundamentals

Key fundamentals

$47.9M

Market cap

-15.2%

Revenue growth (YoY)

5.8%

Gross margin

$16.9M

Free cash flow (USD)

-$394M

Net debt

Net cash position

1.0%

Share dilution

1/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$873.8MFY 2017$959.5MFY 2018$1.8BFY 2019$4.0BFY 2020$8.2BFY 2021$12.4BFY 2022$13.5BFY 2023$14.9BFY 2024$14.4BFY 2025$12.2B
$873.8M$12.2B

Free cash flow by year

2016 → 2025

FY 2016$-395.6MFY 2017$-211.2MFY 2018$-357.8MFY 2019$-534.8MFY 2020$-142.3MFY 2021$-751.5MFY 2022$-54.7MFY 2023$-457.1MFY 2024$247.8MFY 2025$114.7M
-$395.6M$114.7M

Gross margin by year

2021 → 2025

FY 20215.0%FY 20226.2%FY 20235.7%FY 20245.8%FY 20255.8%
5.0%5.8%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

7

Insider sells · 90 days

Earnings

Last reported: Jun 4, 2026 (EPS $-0.60)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider sellInsider Sell $93KSun Jian David · Director · $92.7KJun 16, 2026Filing
  • Insider sellInsider Sell $23KChen Yang Luke · Director · $22.8KJun 16, 2026Filing
  • Insider sellInsider Sell $79KSun Jian David · Director · $79.2KJun 12, 2026Filing
  • Insider sellInsider Sell $54KSun Jian David · Director · $53.7KJun 11, 2026Filing
  • Annual reportAnnual Report FiledJun 4, 2026Filing
  • Insider sellInsider Sell $1KChen Yang Luke · Director · $1.2KMay 29, 2026Filing
  • Insider sellInsider Sell $26KSun Jian David · Director · $25.5KMay 29, 2026Filing
  • Insider sellInsider Sell $26KLuo Jun Justin · Director · $25.5KMay 29, 2026Filing
  • Annual report20-F FiledApr 30, 2026Filing
  • Annual reportAnnual Report FiledApr 9, 2026Filing

Questions

Frequently asked questions

What is 111, Inc.'s market cap?

111, Inc. (YI) has a market capitalization of $47.9M.

What is YI's P/E ratio?

A meaningful P/E ratio is not available for YI — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

When did 111, Inc. last report earnings?

YI last reported earnings on June 4, 2026; the next date is not yet scheduled.

Are insiders buying YI stock?

SEC Form 4 filings show no open-market insider buys at 111, Inc. in the last 90 days (7 sells).

Same arena

Related companies in Medical - Pharmaceuticals

PETS

PetMed Express, Inc.

$46.7M

SDEV

Stablecoin Development Corp.

$35M

NEUP

Neuphoria Therapeutics Inc.

$28.6M

KYNB

Kyntra Bio, Inc.

$28.1M

POM

POMDOCTOR Ltd

$12.7M

HKPD

Cellyan Biotechnology Co., Ltd

$5.7M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.